http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109172596-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c693913f34373a04bc14605f9219491a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27612098934953dc7902d912f4612d28 |
| publicationDate | 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109172596-A |
| titleOfInvention | Mir-99a inhibits the application in inflammation after MI drug in preparation |
| abstract | The invention discloses mir-99a to inhibit the application in inflammation after MI drug in preparation.Compared with the existing technology, the present invention provides mir-99a to inhibit the application in inflammation after MI drug in preparation, the mir-99a is able to suppress myocardial infarction marginal zone TRB2 protein expression, specially on the one hand promotes IL10 expression, and then lower the expression of IL6, reduce myocardial inflammation, on the other hand the expression for raising C/EBP β, promotes M φ to convert to M2, in some instances it may even be possible to the M1 of M φ be promoted to convert to M2 type, inflammatory reaction is further suppressed, there is significant effect. |
| priorityDate | 2018-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.